On 6 Nov 2026, Patel Chem Specialities was priced at ₹123.85, or 24.5× trailing earnings, against an industry P/E of 18.2×, and the shares are 26% below their 52-week high. Sales and net profit grew 26% and 63% a year over 3 years, with ROCE of 16% and ROE of 19%. Debt is 0.18× equity. It is listed on an SME platform with a market cap of ₹308 Cr, ranked 45th of 76 Chemicals companies by market cap; the shares rose 39% over the past year.
- ₹128.05
- ₹128.95
- ₹122.50
- ₹125.40
- 49.6K
Health check
- ReturnsAhead
+38.6% over a year, better than 5 of 7 peers.
- Price tagPricier
P/E 24.5 vs industry 18.2.
- GrowthStrong
Sales +25.5%, profit +63.2% a year over 3 years.
- ProfitabilityAverage
ROCE 16.4% vs peer median 10.6%.
- Balance sheetFair
Debt 0.18× equity, interest covered 20.0×, Piotroski 5 of 9.
- Red flags1 to check
Quarterly profit down 27.1% on a year ago.
Small cap
Market sensitivity
Key metrics
- Market cap
- ₹308 Cr
- Small cap
- P/E
- 24.5
- Industry 18.2
- Price to book
- 3.10
- Peers 2.62
- Dividend yield
- 0.00%
- ROE
- 18.6%
- Peers 11.7%
- ROCE
- 16.4%
- Peers 10.6%
- Debt to equity
- 0.18
- Debt ₹18 Cr
- EPS (TTM)
- ₹5.05
- OPM (TTM)
- 10.9%
- Net margin 9.1%
- Sales growth
- +38.5%
- Latest quarter vs a year ago
- Profit growth
- −27.1%
- Latest quarter vs a year ago
- Price to sales
- 2.24
- EV/EBITDA 16.8
Strengths and risks
Strengths
- Return on equity of 18.6%.
- Quarterly sales up 38.5% on a year ago.
- Positive operating cash flow in each of the last 4 years.
Risks to check
- Quarterly profit down 27.1% on a year ago.
About Patel Chem Specialities
Patel Chem Specialities Limited manufactures and sells cellulose-based excipients. It offers sodium monochloro acetate; BlowTab, a sodium starch glycolate; Disolwell, a croscaremellose sodium; Swellcal, a calcium carboxymethyl cellulose; Rheollose, a sodium carboxymethyl cellulose; and Hindcell, a microcrystalline cellulose. The company also provides PharLub magnesium stearate, AmyloTab C pregelatinized starcg, and sodium chloro acetate. Its products are…
- Headquarters
- Ahmedabad
- Employees
- 137
- Sector
- Basic Materials
- ISIN
- INE161701011
- Website
- patelchem.com
Price range
- Avg volume (3M)
- 47.1K
- 1-year return
- plus 38.6%
- From 52-week high
- minus 25.8%
Peers · Chemicals
| Company | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| NAVINFLUORNavin Fluorine International | 9,010.00 | plus 1.87% | 46,250 | 50.8 | 42.7 | 18.7% | 34.3% | 0.28 | 16.5% | plus 46.1% |
| DEEPAKNTRDeepak Nitrite | 1,533.60 | minus 0.67% | 20,917 | 19.7 | 22.3 | 10.8% | 18.0% | 0.27 | −0.5% | minus 11.9% |
| TATACHEMTata Chemicals | 607.45 | minus 1.36% | 15,475 | – | 12.4 | −3.0% | 12.2% | 0.36 | −4.8% | minus 31.0% |
| DEEPAKFERTDeepak Fertilisers & Petrochemicals Corp. | 1,155.30 | minus 0.69% | 14,599 | 14.8 | 11.5 | 11.2% | 17.6% | 0.76 | 2.6% | minus 22.7% |
| RPELRaghav Productivity Enhancers | 1,780.80 | plus 0.95% | 8,178 | 116.0 | 107.1 | – | 29.9% | 0.02 | 23.5% | plus 95.4% |
| GNFCGujarat Narmada Valley Fertilizers and Chemicals | 451.80 | minus 1.87% | 6,639 | 6.3 | 5.4 | 10.4% | 14.8% | 0.01 | −8.8% | minus 7.2% |
| ACIArchean Chemical Industries | 416.40 | minus 1.95% | 5,141 | 51.3 | 23.2 | 7.7% | 20.0% | 0.28 | −9.2% | minus 34.6% |
| PATELCHEMPatel Chem Specialities | 123.85 | minus 1.24% | 308 | 24.5 | 16.8 | 16.4% | 10.9% | 0.18 | 25.5% | plus 38.6% |
| Median of 7 peers | – | −0.69% | 14,599 | 35.2 | 22.3 | 10.6% | 18.0% | 0.28 | −0.5% | −11.9% |
Quarterly results
This company doesn’t report these figures in a format we can read yet.
Profit & loss
- Sales CAGR 3Y
- +25.5%
- Profit CAGR 3Y
- +63.2%
- ROE
- 18.6%
| ₹ Cr | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| 69.4 | 82.4 | 105 | 137 | |
| – | +18.7% | +27.6% | +30.6% | |
| 63.9 | 70.7 | 89.8 | 120 | |
| 5.5 | 11.7 | 15.3 | 17.2 | |
| 7.9% | 14.2% | 14.6% | 12.5% | |
| 0.3 | 0.2 | 0.3 | 1.7 | |
| 1.1 | 0.9 | 0.8 | 0.9 | |
| 0.6 | 0.7 | 0.7 | 0.9 | |
| – | – | – | −0.1 | |
| 4.1 | 10.4 | 14.1 | 17 | |
| 30.4% | 26.2% | 25.0% | 26.1% | |
| 2.9 | 7.7 | 10.6 | 12.6 | |
| – | +165.3% | +38.0% | +18.8% | |
| 1.16 | 3.08 | 4.25 | – |
Forecast
Balance sheet
| ₹ Cr | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| 1 | 1 | 17.9 | 24.9 | |
| 10.9 | 18.5 | 17.5 | 74.6 | |
| 11.8 | 15.5 | 14.9 | 18.3 | |
| 13.4 | 12 | 15.1 | 24.5 | |
| 37.1 | 47 | 65.3 | 142 | |
| 13.6 | 16.3 | 26.2 | 51.9 | |
| – | 2.5 | 12.4 | 21.8 | |
| 0.1 | 0.7 | 0.7 | 36.7 | |
| 23.4 | 27.6 | 26 | 31.9 | |
| 37.1 | 47 | 65.3 | 142 |
Cash flow
| ₹ Cr | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| 2 | 6.1 | 2.4 | 10.5 | |
| −3.3 | −5.9 | −10.6 | −19.4 | |
| 0.8 | 0.3 | 8.4 | 44.8 | |
| −0.5 | 0.5 | 0.1 | 35.9 | |
| −3.9 | −3.4 | −10.6 | −19.4 | |
| −2 | 2.7 | −8.3 | −8.9 |
Shareholding pattern
This company is listed only on BSE, so there’s no NSE category split. See Major shareholders below for the named holders.
Major shareholders
Filings & events
News
No recent news coverage found.